Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. November 2011 08:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Attend the 23rd Annual Piper Jaffray Health Care Conference

SALT LAKE CITY, Nov. 21, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it will meet with investors at the 23rd Annual Piper Jaffray Health Care Conference on...
01. November 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Reports First Quarter Fiscal Year 2012 Results

SALT LAKE CITY, Nov. 1, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its first fiscal quarter ending September 30, 2011. Revenue for the first fiscal...
11. Oktober 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Announce Fiscal 2012 First Quarter Results on Tuesday, November 1, 2011

SALT LAKE CITY, Oct. 11, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the first fiscal quarter following the close of market on...
08. September 2011 16:15 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Makes Strategic Debt Investment With Exclusive Option to Acquire Crescendo Bioscience

SALT LAKE CITY, Sept. 8, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (Nasdaq:MYGN) today announced that it has made a $25 million strategic debt investment in Crescendo Bioscience of South San...
30. August 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference

SALT LAKE CITY, Aug. 30, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter Meldrum, President and CEO, is scheduled to present at the Morgan Stanley Healthcare...
15. August 2011 16:15 ET | Quelle: Myriad Genetics, Inc.

Myriad Announces New $200 Million Share Repurchase Program

SALT LAKE CITY, Aug. 15, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its Board of Directors has authorized a new $200 million stock repurchase program. "This...
09. August 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Reports Fourth Quarter and Fiscal Year 2011 Results

SALT LAKE CITY, Aug. 9, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its fourth fiscal quarter and fiscal year ending June 30, 2011. Revenue for the fourth...
29. Juli 2011 13:56 ET | Quelle: Myriad Genetics, Inc.

Myriad Applauds the Court of Appeals' Decision to Uphold Gene Patenting

SALT LAKE CITY, July 29, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) reported today that the United States Court of Appeals for the Federal Circuit declared that the composition of...
19. Juli 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Announce Fiscal Fourth Quarter and Fiscal Year 2011 Results on Tuesday, August 9, 2011

SALT LAKE CITY, July 19, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the fiscal fourth quarter and fiscal year 2011 following...
09. Juni 2011 16:05 ET | Quelle: Myriad Genetics, Inc.

OnDose(R) Study Demonstrates Need for Improved Dosing Approach for Colorectal Cancer Patients

SALT LAKE CITY, June 9, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in Clinical Colorectal Cancer entitled "Body Surface Area-based Dosing of...

Vorherige Seite